Companies: 10,795·Total market cap: $144.5T
Evotec SE

Evotec SE

EVONASDAQHealthcare● Active
$2.81
+$0.01(+0.36%)
Market Cap$998078471
P/E Ratio
52W High$4.44
52W Low$2.31

Evotec SE(EVO)股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

evo · 股价预测 · 7 位分析师(近3月)· FMP · 更新于 2026年6月8日

分析师评级与共识

基于过去 3 个月内 7 位华尔街分析师

SellBuy

Buy

7 位分析师

共识

评级分布

Strong Buy
0
Buy
4
Hold
3
Sell
0
Strong Sell
0
合计: 7 · 买入占比: 57.1%

12 个月目标价

High

$7.00

Consensus

$7.00

+149.1% upside

Low

$7.00

Median: $7 · Last Close: $2.81

Evotec SE(EVO)的分析师共识为 Buy,基于过去 3 个月内 7 位华尔街分析师的评级。EVO 的 12 个月平均目标价为 $7.00,相对当前价 $2.81 代表 +149.1% 的潜在上行空间。

12 个月目标价预测

历史收盘价 + 分析师 12 个月目标价预测区间

分析师目标价覆盖不足,无法为该股票生成预测图表。

短期股价预测

算法生成 · 每日更新

DatePredicted PriceChange
2026-06-09$2.800.28%

1-day model range: $2.78–$2.82. Peak: $2.82 (-0.28%).

长期股价预测

年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$2-37.8%
2028$1-50.8%
2029$1-56.4%
2030$1-59.1%
2031-60.6%
Confidence:Medium

基于技术分析的股价预测

14 项技术面信号(SMA×6 + EMA×6 + RSI + MACD)· EEAT 方法论透明

Market Sentiment

BEARISH

Based on 14 technical indicators

0%7%93%
0Buy
1Neutral
13Sell
RSI (14)53.2Neutral
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · EVO · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$2.88SELL
MA 10$2.93SELL
MA 20$2.89SELL
MA 50$2.92SELL
MA 100$3.07SELL
MA 200$3.27SELL
Current $EVO · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$2.87SELL
EMA 10$2.90SELL
EMA 20$2.92SELL
EMA 50$2.95SELL
EMA 100$3.04SELL
EMA 200$3.27SELL
Current $EVO · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:
HC Wainwright & Co.2025-08-14
Maintains
BuyBuy
HC Wainwright & Co.2024-11-07
Maintains
BuyBuy
HC Wainwright & Co.2024-08-15
Maintains
BuyBuy
HC Wainwright & Co.2024-05-23
Maintains
BuyBuy
HC Wainwright & Co.2024-04-25
Maintains
BuyBuy
HC Wainwright & Co.2023-08-31
Maintains
BuyBuy
HC Wainwright & Co.2023-07-12
Maintains
BuyBuy
Morgan Stanley2023-06-23
Upgrade ↑
Equal WeightOverweight
B of A Securities2023-06-16
Downgrade ↓
BuyNeutral
Citigroup2023-06-08
Upgrade ↑
NeutralBuy

Wall Street analysts have recently issued updated ratings on Evotec SE (EVO) stock. Of the recent 19 rating actions, 3 were upgrades and 5 were downgrades. 7 analysts currently cover EVO.

分析师推荐趋势

Buy ratings11
Hold ratings00
Sell ratings00

EVO analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.

财务预测:EPS 与营收一致预期

Revenue This Year

$752M

↓ 17.1% YoY

Revenue Next Year

$822M

↑ 9.2% YoY

EPS This Year

$-0.34

EPS Next Year

$-0.06

↓ 82.8% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast EVO EPS of $-0.34 for the current fiscal year, based on estimates from 2 analysts. The EVO revenue forecast is $752M for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

EVO 股价预测由两类独立数据源支撑:来自 7 位华尔街分析师(S&P Global / FMP)的共识评级,以及基于历史日终价计算的技术分析。EVO 的共识目标价为 $7.00(+149.1% 上行空间),分析师共识为 Buy。

EVO 的短期预测(明日)为 $2.80(-0.28%)。 EVO 对 2027 年的股价预测均值为 $2。 EVO 对 2030 年的预测区间为 $1–$1。

Evotec SE 在 NASDAQ 上市,代码 EVO。EVO 在 2027 年的整体展望偏积极,在覆盖分析师中约 57% 对应 Buy 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

常见问题

EVO 预测 · 8 个问题

根据 7 位华尔街分析师,EVO 的 12 个月平均目标价为 $7.00,最高 $7.00、最低 $7.00。若有图表,中位目标价可在上方查看。相对当前价 $2.81,隐含约 +149.1% 的上行空间。

EVO 目标价EVO 分析师目标价EVO 12个月目标价目标价 EVO

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.